IntrinsicIntrinsic
← Scroll for more →

Financial Statements — EVMN

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Cash & Equivalents60.0348.3244.0626.82
Short-term Investments140.76163.15105.1449.24
Total Current Assets204.25215.86153.4881.94
Property, Plant & Equipment1.651.640.990.97
Total Non-current Assets*97.70106.6071.472.60
Total Assets301.95322.46224.9584.54
Accounts Payable5.044.057.763.58
Total Current Liabilities17.4910.6017.9110.42
Total Non-current Liabilities*6.877.301.470.26
Total Liabilities24.3617.9019.3810.68
Retained Earnings(275.01)(242.76)(221.09)(192.82)
Total Stockholder Equity277.59304.56205.57(183.14)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Total Revenue0.000.000.0010.00
Research & Development26.4117.3220.4019.64
Selling, General & Admin8.486.649.313.69
Total Operating Expenses34.9023.9529.7223.33
Operating Income(34.90)(23.95)(29.72)(13.33)
Pretax Income*(32.25)(21.67)(28.27)(12.47)
Tax Provision0.000.000.000.00
Net Income(32.25)(21.67)(28.27)(12.47)
Basic EPS(0.89)(0.64)15.14(8.07)
Diluted EPS(0.89)(0.64)15.14(8.07)
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Operating Cash Flow(20.32)(27.50)(16.70)(59.74)
Capital Expenditures0.180.080.100.13
Free Cash Flow*(20.50)(27.59)(16.80)(59.87)
Investing Cash Flow31.29(85.36)(122.90)7.59
Financing Cash Flow0.53117.11156.8563.92
← Scroll for more columns →

* Derived from reported values